# Parabilis Medicines, Inc.: Form 8-K, filed Jun 11, 2026

- Company: [Parabilis Medicines, Inc.](/companies/pbls.md) (CIK 1657677)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 16:12 ET
- Period: 2026-06-09
- Accession: 0001193125-26-267550
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1657677/000119312526267550/ck0001657677-20260609.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1657677/000119312526267550/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1657677/000119312526267550/ck0001657677-20260609.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-267550. Last ingested by Listed: Nov 13, 2026, 15:39 ET. No prices; not investment advice.
